Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01013792 · ClinicalTrials.gov registry record · NA
A Comparison of an Investigational Dressing to Tegaderm Matrix Wound Dressing in the Management of Diabetic Foot Ulcers
A NA study, sponsored by Solventum US.
- Terminated
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01013792 is a NA study that was terminated before completion, run by Solventum US. The registered enrollment target is 30 participants.
The verdict
NCT01013792, a NA study, was terminated before completion, sponsored by Solventum US.
- TERMINATED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The primary objective is to: * Assess the effect of the Non-adherent study dressing to 3M Tegaderm Matrix Dressing with PHI technology on wound healing in patients with a diabetic foot ulcer. Secondary objectives are to: * Assess the adverse events that occur in subjects randomized to the investigational dressing in comparison to subjects randomized to the Tegaderm Matrix Dressing with PHI technology. * Assess the costs of using the investigational dressing compared to the Tegaderm Matrix Dressing with PHI technology. * Assess and compare the impact that these dressings have on patients' quality of life. * Assess the wound's biological response and pH to the study dressings.
Interventions
- DEVICE Wound Dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-11 |
| Est. Completion | 2012-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01013792
The ClinicalTrials.gov registry entry for NCT01013792 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Solventum US, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Wound Dressing is the first listed.
NCT01013792 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01013792 about?
NCT01013792 is a clinical study titled "A Comparison of an Investigational Dressing to Tegaderm Matrix Wound Dressing in the Management of Diabetic Foot Ulcers". The primary objective is to: * Assess the effect of the Non-adherent study dressing to 3M Tegaderm Matrix Dressing with PHI technology on wound healing in patients with a diabetic foot ulcer. Secondary objectives are to: * Assess the adverse events that occur in subjects randomized to the investi...
What is the current status of trial NCT01013792?
This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2009-11. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01013792?
The interventions under investigation include: Wound Dressing (DEVICE).
Who is sponsoring clinical trial NCT01013792?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.